Patents Assigned to Intrance International AB - Justia Patents Search

Patents Assigned to Intrance International AB

Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders

Patent number: 11547689

Abstract: A method of treating patients by using a pharmaceutical composition for intra-intestinal administration comprises (i) a dopamine replacement agents, (ii) a dopamine decarboxylase inhibitor (DDI), and (iii) a COMT inhibitor where the composition is continuously administrated.

Type: Grant

Filed: March 22, 2019

Date of Patent: January 10, 2023

Assignee: Intrance International AB

Inventor: Roger Bolsöy
Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof

Patent number: 11413262

Abstract: A pharmaceutical gel composition for intra-intestinal administration comprises (i) a dopamine replacement agent, (ii) a dopamine decarboxylase inhibitor (DDI), and (iii) a COMT inhibitor.

Type: Grant

Filed: August 13, 2020

Date of Patent: August 16, 2022

Assignee: Intrance International AB

Inventor: Roger Bolsöy